Eberbach, 27 July 2022. GELITA AG has established a center for biotechnology. At the Biotech Hub in Frankfurt am Main, biologists and biotechnologists work, among other things, on the development of proteins from biotechnological processes for applications in nutrition, cosmetics, and pharmaceutical and medical products. The investment in the new site represents a milestone for GELITA on its way to a broader, sustainable product portfolio.
GELITA’s investment in the Biotech Hub highlights a strong focus on biotechnology as a forward-looking technology of the 21st century. This strategic step reflects the company’s dedication to innovation, sustainable growth, and meeting increasing global market demands with future-ready solutions. The new research laboratory reinforces this commitment by providing a foundation for continuous innovation and long-term value creation. GELITA collagen peptides from animal raw materials have recorded high growth rates in recent years. As a pioneer in the clinical research and production of specific Bioactive Collagen Peptides, the company also plans to systematically expand its expertise in the field of biotechnology. A move that will secure its core business in the long term and open up new, lucrative market segments.
In the new research laboratory located in the Höchst Industrial Park in Frankfurt am Main, the management and the team are developing and optimizing microorganisms that can produce almost unlimited varieties of organic compounds. Their initial focus is on proteins for the food and cosmetics industries and companies in the pharmaceutical and medical sectors. The advantages are clear: Biotechnology overcomes the limitations of conventional manufacturing processes. Biotechnologically produced proteins make it possible to manufacture alternatives of consistently high quality and with optimized properties - in some cases even more resource-efficiently and sustainably than by conventional means.
Leveraging Geographical Advantages
GELITA sees clear geographical advantages in its decision to locate in Frankfurt with its proximity to the biotech-based industrial and research landscape of the Main metropolis. Among other things, the company hopes to receive applications from well-trained, experienced specialists. "As a fast-growing, innovation-driven company, we offer career starters and professionals diversified tasks in a young, friendly team as well as a wide range of development opportunities." The company plans to continually expand the team in the coming years.